{{Rsnum
|rsid=361072
|Gene=PIK3CB
|Chromosome=3
|position=138759702
|Orientation=plus
|GMAF=0.2984
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PIK3CB
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 27.4 | 48.7 | 23.9
| HCB | 95.6 | 4.4 | 0.0
| JPT | 96.5 | 3.5 | 0.0
| YRI | 43.5 | 43.5 | 12.9
| ASW | 35.7 | 55.4 | 8.9
| CHB | 95.6 | 4.4 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 46.5 | 44.6 | 8.9
| LWK | 47.3 | 44.5 | 8.2
| MEX | 48.3 | 44.8 | 6.9
| MKK | 33.3 | 46.8 | 19.9
| TSI | 19.6 | 51.0 | 29.4
| HapMapRevision=28
}}{{omim
|desc=PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, BETA; PIK3CB
|id=602925
|rsnum=361072
}}

{{PMID|17971428}} A single-nucleotide polymorphism in the p110beta gene promoter is associated with partial protection from insulin resistance in severely obese adolescents.

{{PMID|17977952}} Association analysis indicates that a variant GATA-binding site in the PIK3CB promoter is a Cis-acting expression quantitative trait locus for this gene and attenuates insulin resistance in obese children.

{{PMID|18398029}} Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.

{{PMID|18772892|OA=1
}} Can genes for mammographic density inform cancer aetiology?

{{PMID|19097921}} In obese and non-obese adults, the cis-regulatory rs361072 promoter variant of PIK3CB is associated with insulin resistance not with type 2 diabetes.

{{PMID|20107106|OA=1
}} Impact of rs361072 in the phosphoinositide 3-kinase p110beta gene on whole-body glucose metabolism and subunit protein expression in skeletal muscle.

{{PMID Auto
|PMID=24114431
|Title=SNPs within the GH signaling pathway are associated with the early IGF-I response to GH replacement therapy in GHD adults
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}